Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34165508

Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2021 Aug 1
First author
Friedl TWP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Aug 1;7(8):1121-1123. doi: 10.1001/jamaoncol.2021.1516.
    note
    Source null
    related pmid
    34165515
    relationship
    Comment in
  2. citation
    JAMA Oncol. 2022 Jan 1;8(1):171-172. doi: 10.1001/jamaoncol.2021.5768.
    note
    Source null
    related pmid
    34792528
    relationship
    Comment in
  3. citation
    JAMA Oncol. 2022 Jan 1;8(1):171. doi: 10.1001/jamaoncol.2021.5765.
    note
    Source null
    related pmid
    34792535
    relationship
    Comment in
  4. citation
    Thorac Cancer. 2022 Feb;13(3):519-520. doi: 10.1111/1759-7714.14257.
    note
    Source null
    related pmid
    34978157
    relationship
    Comment in

Authors and identifiers

  1. name
    Friedl TWP
    type
    Author
  2. name
    Fehm T
    type
    Author
  3. name
    Müller V
    type
    Author
  4. name
    Lichtenegger W
    type
    Author
  5. name
    Blohmer J
    type
    Author
  6. name
    Lorenz R
    type
    Author
  7. name
    Forstbauer H
    type
    Author
  8. name
    Fink V
    type
    Author
  9. name
    Bekes I
    type
    Author
  10. name
    Huober J
    type
    Author
  11. name
    Jückstock J
    type
    Author
  12. name
    Schneeweiss A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Friedl TWP
    type
    Author
  2. name
    Fehm T
    type
    Author
  3. name
    Müller V
    type
    Author
  4. name
    Lichtenegger W
    type
    Author
  5. name
    Blohmer J
    type
    Author
  6. name
    Lorenz R
    type
    Author
  7. name
    Forstbauer H
    type
    Author
  8. name
    Fink V
    type
    Author
  9. name
    Bekes I
    type
    Author
  10. name
    Huober J
    type
    Author
  11. name
    Jückstock J
    type
    Author
  12. name
    Schneeweiss A
    type
    Author
bibliography ids
  1. nci-bib-99cc0792e769e47a523bb06f
book metadata
content sha256
20db54feeeef08a9a0b35980c127171baa96b480cfeffd94362571c70a082cf3
document type
citation
dois
  1. 10.1001/jamaoncol.2021.1854
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34165508
immutable id
pubmed:34165508@20db54feeeef08a9a0b35980c127171baa96b480cfeffd94362571c70a082cf3
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
8
name
JAMA oncology
nlm unique id
101652861
pages
1149-1157
volume
7
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Aug 1;7(8):1121-1123. doi: 10.1001/jamaoncol.2021.1516.
    note
    Source null
    related pmid
    34165515
    relationship
    Comment in
  2. citation
    JAMA Oncol. 2022 Jan 1;8(1):171-172. doi: 10.1001/jamaoncol.2021.5768.
    note
    Source null
    related pmid
    34792528
    relationship
    Comment in
  3. citation
    JAMA Oncol. 2022 Jan 1;8(1):171. doi: 10.1001/jamaoncol.2021.5765.
    note
    Source null
    related pmid
    34792535
    relationship
    Comment in
  4. citation
    Thorac Cancer. 2022 Feb;13(3):519-520. doi: 10.1111/1759-7714.14257.
    note
    Source null
    related pmid
    34978157
    relationship
    Comment in
outcomes validated
false
pmid
34165508
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
6f37cd315302bb53c63c76820d6d2ecc0068abffd9bc33a5e59ee6f436a68f1a
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Aug 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34165508/
title
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.

Preserved source evidence · Not medical advice